Retrospective analysis of the efficacy and safety of eribulin therapy for metastatic breast cancer in daily practice

BACKGROUND: Evidence of eribulin therapy for metastatic breast cancer (MBC) in clinical practice is not well documented. METHODS: We retrospectively analyzed the safety and efficacy of eribulin in 29 MBC patients from 2011 to 2016 at Fukuoka University Hospital. RESULTS: The median patient age, numb...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Tanaka, Toshihiro, Ueno, Miho, Nakashima, Yuta, Chinen, Shotaro, Sato, Eiichi, Masaki, Michio, Mogi, Ai, Sasaki, Hidenori, Tamura, Kazuo, Takamatsu, Yasushi
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5588851/
https://ncbi.nlm.nih.gov/pubmed/28741868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12482
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars